Innovative drug target discovery

Using the proprietary LITOseek™ platform and database, Novigenix can help biopharma discover new drug targets with high efficiency and efficacy:

  • RNA is the first biochemical level of activated immune cell response and our platform measures the profile of the patient’s integrated immune response
  • Our approach enables patient profiling reflecting phenotypic heterogeneity using stabilised whole blood analysis.
  • We can help shape your strategic focus in drug discovery and development by providing intelligent data-driven patient insights
  • Our solutions can help you accelerate your innovation cycle in translational medicine

Learn more

The LITOSeek™ Drug Target Discovery platform provides discovery of novel drug targets based on patients’ response to onset of disease, as well as in patient sub-populations that have shown resistance to therapy.